I
Immucell CorpICCC
ImmuCell Corporation (Nasdaq: ICCC) is an animal-health biologics company that operates in the fast-growing market for calf health solutions. It develops, manufactures and commercializes the First Defense® line of products that provides Immediate Immunity through colostrum-derived, orally delivered antibodies against the principal viral and bacterial causes of scours. Scours (neonatal calf diarrhea) is one of the most prevalent and deadly diseases in neonatal calves.
US StocksHealthcareSmall CapDefense & AerospaceGrowth Stocks
ICCC の価格トレンド
Immucell Corp · TradingView フルチャート
NASDAQ:ICCC